Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma.

Oncoimmunology · 2024 · PMC11445892 · PMID 39359389

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

Positive cases for p-STAT1, however, showed a trend toward a worse OS compared to the negative ones (26.4 vs. 45.1 months, HR 1.5, [95%CI 0.9–2.4], p = 0.09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.